![Stephan Walz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephan Walz
Director/Board Member at
BM3EAC CORP.
Net worth: 200 000 $ as of 30/07/2026
Profile
Stephan Walz is the founder of Aristo Pharma GmbH, serving as Chief Executive Officer since its founding in 2008.
Current jobs include Managing Director at Passauer Pharma GmbH since 2019 and Independent Non-Executive Director at BM3EAC Corp.
Former jobs include Chief Executive Officer at Invent Invest Holding SL, Chief Executive Officer at neuraxpharm Arzneimittel GmbH from 2016 to 2018, Director at Albrecht, Prock & Partners AG, Director at 3w Beratungs- Und Beteiligungs GmbH, and Head-Production & Development at Lindopharm GmbH.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BM3EAC CORP. 0.32% | 30/12/2024 | 20,000 ( 0.32% ) | 200 000 $ | 30/07/2026 |
Stephan Walz active positions
| Companies | Position | Start |
|---|---|---|
| BM3EAC CORP. | Director/Board Member | - |
Passauer Pharma GmbH
 Passauer Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Executive Officer | 31/10/2019 |
Former positions of Stephan Walz
| Companies | Position | End |
|---|---|---|
neuraxpharm Arzneimittel GmbH
 neuraxpharm Arzneimittel GmbH Pharmaceuticals: GenericHealth Technology Manufactures pharmaceutical products for central nervous system disorders | Chief Executive Officer | 04/09/2018 |
Albrecht Prock & Partners AG
 Albrecht Prock & Partners AG Miscellaneous Commercial ServicesCommercial Services Operates as a strategy consultancy and advisory firm that specializes in M&A assistance, strategy development, operations and talent management | Director/Board Member | - |
3w Beratungs- Und Beteiligungs GmbH | Director/Board Member | - |
Aristo Pharma GmbH
 Aristo Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes sought-after active ingredients | Chief Executive Officer | - |
Lindopharm GmbH
 Lindopharm GmbH Pharmaceuticals: MajorHealth Technology Produces human and veterinary drugs, as well as food supplementary products | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Lindopharm GmbH
Lindopharm GmbH Pharmaceuticals: MajorHealth Technology Produces human and veterinary drugs, as well as food supplementary products | Health Technology |
Invent Invest Holding SL
 Invent Invest Holding SL Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
neuraxpharm Arzneimittel GmbH
neuraxpharm Arzneimittel GmbH Pharmaceuticals: GenericHealth Technology Manufactures pharmaceutical products for central nervous system disorders | Health Technology |
Aristo Pharma GmbH
Aristo Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes sought-after active ingredients | Health Technology |
Albrecht Prock & Partners AG
Albrecht Prock & Partners AG Miscellaneous Commercial ServicesCommercial Services Operates as a strategy consultancy and advisory firm that specializes in M&A assistance, strategy development, operations and talent management | Commercial Services |
Passauer Pharma GmbH
Passauer Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
BM3EAC Corp.
 BM3EAC Corp. Financial ConglomeratesFinance Operates as a special purpose acquisition company | Finance |
3w Beratungs- Und Beteiligungs GmbH |
- Stock Market
- Insiders
- Stephan Walz
